LAUSR

We describe the case of a 49‐year‐old gentleman who presented with a generalized urticarial rash with wheals, itching, and angioedema 6 weeks after the initiation of levothyroxine (Brand‐1) tablets for hypothyroidism. He was diagnosed with hypothyroidism while being evaluated for carpal tunnel syndrome. His thyroid‐stimulating hormone (TSH) level before initiation of therapy was 170.9 mIU/L. There was no history of allergy to drugs, foods, or any other medications before the development of the present allergic reaction. There was no history to suggest chronic urticaria. He discontinued the medication by himself following which his rash subsided with complete resolution of urticarial lesions in 3 weeks. Clinical examination at the time of presentation was unremarkable. On follow‐up after stopping the medication, his TSH was 28.3 mIU/L, T4 was 4.4 mcg/dL, and free T4 was 1.1 ng/dL. The titers of antithyroglobulin and antithyroid peroxidase were 1226 IU/ mL and 705 IU/mL, respectively. Immunoglobulin E (IgE) was 102.2 U/mL (N: 0–378). Besides IgE, antinuclear antibody (ANA), C3, and C4 were done, these were normal. Anti‐C1q antibody testing was also negative. He was started on levothyroxine (Brand‐2) 12.5 mcg and on the same day developed urticarial rash [Figure 1] that subsided completely after stopping the medication. Subsequently, he was initiated on 12.5 mcg of levothyroxine (Brand‐3), which he tolerated well, without the development of allergic reactions. It was decided to gradually increase the dosage of levothyroxine over the next 4 weeks.